SPONSOR
Sichuan University
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1
Conditions studied: Esophageal Squamous Cell Carcinoma (ESCC)ImmunotherapyNSCLCLow Dose RadiotherapyPD-1 InhibitorLeptomeningeal MetastasisLung CancerNon-small Cell Lung Cancer
Sichuan University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Esophageal Squamous Cell Carcinoma (ESCC), Immunotherapy, NSCLC, Low Dose Radiotherapy.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sichuan University
How many clinical trials has Sichuan University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Sichuan University, of which 3 are actively recruiting participants. These trials cover conditions including Esophageal Squamous Cell Carcinoma (ESCC), Immunotherapy, NSCLC. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sichuan University research focus on?
Sichuan University clinical trials span Esophageal Squamous Cell Carcinoma (ESCC), Immunotherapy, NSCLC, Low Dose Radiotherapy, PD-1 Inhibitor, and additional conditions. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sichuan University clinical trial?
To participate in a Sichuan University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sichuan University trials with current recruitment status updated daily.
Clinical Trials by Sichuan University
NCT06603402 Phase 2
Recruiting
Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
Esophageal Squamous Cell Carcinoma (ESCC)
NCT06431685 Phase 1
Recruiting
Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
NSCLC
NCT06877299 Phase 2
Recruiting
Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer
Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology